Opportunity status:
Open
Funders:
Medical Research Council (MRC)
Co-funders:
Foreign, Commonwealth and Development Office (FCDO)
Funding type:
Grant
Award range:
£150,000 - £2,000,000
Publication date:
9 April 2025
Opening date:
30 April 2025 9:00am UK time
Closing date:
16 July 2025 4:00pm UK time
Apply for funding to support applied research that will address global health challenges and inequities.
We will accept applications of all sizes, including large research projects and small to medium-scale applications.
We are looking to develop a portfolio of high-quality global research, which will be diverse, promote multidisciplinarity and strengthen global health research capacity.
You must be invited to apply for stage two of this applied global health research funding opportunity.
You can only apply for this funding opportunity if we have invited you to do so, following a successful stage one application.
To lead a project, you must be based at an eligible organisation. Check if your organisation is eligible.
Who is eligible to apply
To be eligible to apply for this funding opportunity you must be eligible as an individual who is based at either an eligible UK research organisation, or based in a:
If you do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming, if it is successful:
Who is not eligible to apply
You are not eligible to apply if you are based in a high-income country (does not include UK project leads, who are eligible), or in India. You are not eligible to be project lead but may be eligible to be project co-lead (international).
It is expected that researchers from India and any high-income countries make a significant contribution to their own research costs, including covering their own overheads. Where India is included in a project there must be at least two other LMICs involved in the project.
UK Research and Innovation (UKRI) is unable to support Official Development Assistance (ODA) research and innovation activities taking place in China, or where China is the direct beneficiary. This means the ODA compliance statement submitted by applicants should not identify China as part of the project’s rationale or justification. Providing no UK funding flows to China, it is permissible for China-based researchers to be involved in UKRI funded activities when part of a consortia of internationally-based researchers. China-based researchers are not eligible to lead applications.
Equality, diversity and inclusion
We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers.
We support people to work in a way that suits their personal circumstances. This includes:
UKRI can offer disability and accessibility support for UKRI applicants and grant holders during the application and assessment process.
Sponsor Institute/Organizations: Medical Research Council (MRC)
Sponsor Type: Corporate/Non-Profit
Address: Polaris House North Star Avenue Swindon, SN2 1FL United Kingdom
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jul 16, 2025
Jul 16, 2025
$150,000
up to 2,000,000
Affiliation: Medical Research Council (MRC)
Address: Polaris House North Star Avenue Swindon, SN2 1FL United Kingdom
Website URL: https://www.ukri.org/opportunity/applied-global-health-research-invited-stage-two/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.